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Introduction
We are developing 3H AMS to measure 3H activity of mg sized biological samples. Presently, most biological samples are assayed for 3H content using decay counting techniques. While the technique can be used on small samples, 3H decay counting lacks the sensitivity and specificity needed for very low-specific activity materials. 3He in-growth techniques for the measurement of 3H at low concentrations has the sensitivity and specificity required but needs relatively large samples. When compared to decay counting techniques, 3H AMS promises a 100-to 1000-fold improvement in detection sensitivity for assaying mg sized biological samples. 
Motivation

Current Status
The status of 3H AMS can be sub-divided into two different areas: 1) spectrometer performance and 2) efforts to prepare samples. Current spectrometer performance, as demonstrated in Figure 1 , is more than adequate for preliminary 3H biomedical work. 3H:IH ratios as high as 10-9 Our efforts to develop a 3H AMS sample preparation technique for complex biological samples have met with mixed success. As has been done for 14C biomedical AMS [3], it is necessary with 3H AMS to develop a one-or two-step technique in which organic samples are reduced into a form suitable for the ion source. Our initial attempt at sample preparation was to directly reduce samples on titanium powder at 850°C in a simple single tube system.
Although this technique worked well enough to produce the data shown in are reduced to a form suitable for the ion source has proved to be a very difficult coupled organic/inorganic chemistry problem.
As discussed above, one of the techniques that we have tried works poorly while another shows promise. This latter technique, however, has yet to be tried on biological samples.
To make use of this method, we are considering using cupric oxide to combust our biological samples into water and other gases, and then transferring the water into our reduction stage. 
Conclusion
We believe the successful development and demonstration of 3H AMS will have a major impact on biomedical research. Such technology is critically important for evaluating effects of exposure to environmental levels of toxic agents and for monitoring effects of pharmaceuticals at low doses.
